VERO vs. TMDIF, TNON, STSS, INVO, QNRX, IONM, VAPO, GMVDF, AEMD, and RSLS
Should you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Titan Medical (TMDIF), Tenon Medical (TNON), Sharps Technology (STSS), INVO Bioscience (INVO), Quoin Pharmaceuticals (QNRX), Assure (IONM), Vapotherm (VAPO), G Medical Innovations (GMVDF), Aethlon Medical (AEMD), and ReShape Lifesciences (RSLS). These companies are all part of the "surgical & medical instruments" industry.
Venus Concept (NASDAQ:VERO) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, community ranking, valuation, risk, media sentiment and analyst recommendations.
Venus Concept received 34 more outperform votes than Titan Medical when rated by MarketBeat users.
87.4% of Venus Concept shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 51.4% of Venus Concept shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Titan Medical has lower revenue, but higher earnings than Venus Concept. Venus Concept is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.
Titan Medical has a net margin of 0.00% compared to Venus Concept's net margin of -51.00%. Titan Medical's return on equity of 126.94% beat Venus Concept's return on equity.
In the previous week, Venus Concept had 6 more articles in the media than Titan Medical. MarketBeat recorded 9 mentions for Venus Concept and 3 mentions for Titan Medical. Titan Medical's average media sentiment score of 0.46 beat Venus Concept's score of 0.15 indicating that Titan Medical is being referred to more favorably in the news media.
Venus Concept has a beta of 0.65, meaning that its share price is 35% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500.
Summary
Titan Medical beats Venus Concept on 9 of the 14 factors compared between the two stocks.
Get Venus Concept News Delivered to You Automatically
Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VERO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Venus Concept Competitors List
Related Companies and Tools
